The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction

Eugene Oh, Harvey Chim, Hooman Soltanian

Research output: Contribution to journalReview article

Abstract

Breast reconstruction following mastectomy has become, in many centers the standard of care. An increasingly encountered trend is the use of neoadjuvant chemotherapy to downstage high stage tumors and to decrease tumor burden prior to definitive oncologic surgery. These agents clearly provide a survival benefit, but also have the potential to adversely affect the surgical course of immediate and delayed breast reconstruction. The use of new biologic and hormonal agents may also have effects on surgery and reconstruction. Furthermore, chemotherapeutic agents as a whole may impair cellular functions necessary for normal recovery from surgery. In this paper we present a concise review for the reconstructive surgeon on adverse effects of chemotherapeutic, hormonal and biologic agents used for treatment of breast cancer, important perioperative issues, and also discuss their potential effect on breast reconstruction.

Original languageEnglish (US)
JournalJournal of Plastic, Reconstructive and Aesthetic Surgery
Volume65
Issue number10
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Mammaplasty
Adjuvant Chemotherapy
Biological Factors
Mastectomy
Standard of Care
Tumor Burden
Breast Neoplasms
Drug Therapy
Neoplasms
Therapeutics

Keywords

  • Biologic
  • Breast cancer
  • Breast reconstruction
  • Chemotherapy
  • Hormonal

ASJC Scopus subject areas

  • Surgery

Cite this

The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction. / Oh, Eugene; Chim, Harvey; Soltanian, Hooman.

In: Journal of Plastic, Reconstructive and Aesthetic Surgery, Vol. 65, No. 10, 01.10.2012.

Research output: Contribution to journalReview article

@article{b29f9aa098314f8093854e70ec8e3a55,
title = "The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction",
abstract = "Breast reconstruction following mastectomy has become, in many centers the standard of care. An increasingly encountered trend is the use of neoadjuvant chemotherapy to downstage high stage tumors and to decrease tumor burden prior to definitive oncologic surgery. These agents clearly provide a survival benefit, but also have the potential to adversely affect the surgical course of immediate and delayed breast reconstruction. The use of new biologic and hormonal agents may also have effects on surgery and reconstruction. Furthermore, chemotherapeutic agents as a whole may impair cellular functions necessary for normal recovery from surgery. In this paper we present a concise review for the reconstructive surgeon on adverse effects of chemotherapeutic, hormonal and biologic agents used for treatment of breast cancer, important perioperative issues, and also discuss their potential effect on breast reconstruction.",
keywords = "Biologic, Breast cancer, Breast reconstruction, Chemotherapy, Hormonal",
author = "Eugene Oh and Harvey Chim and Hooman Soltanian",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.bjps.2012.04.053",
language = "English (US)",
volume = "65",
journal = "Journal of Plastic, Reconstructive and Aesthetic Surgery",
issn = "1748-6815",
publisher = "Churchill Livingstone",
number = "10",

}

TY - JOUR

T1 - The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction

AU - Oh, Eugene

AU - Chim, Harvey

AU - Soltanian, Hooman

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Breast reconstruction following mastectomy has become, in many centers the standard of care. An increasingly encountered trend is the use of neoadjuvant chemotherapy to downstage high stage tumors and to decrease tumor burden prior to definitive oncologic surgery. These agents clearly provide a survival benefit, but also have the potential to adversely affect the surgical course of immediate and delayed breast reconstruction. The use of new biologic and hormonal agents may also have effects on surgery and reconstruction. Furthermore, chemotherapeutic agents as a whole may impair cellular functions necessary for normal recovery from surgery. In this paper we present a concise review for the reconstructive surgeon on adverse effects of chemotherapeutic, hormonal and biologic agents used for treatment of breast cancer, important perioperative issues, and also discuss their potential effect on breast reconstruction.

AB - Breast reconstruction following mastectomy has become, in many centers the standard of care. An increasingly encountered trend is the use of neoadjuvant chemotherapy to downstage high stage tumors and to decrease tumor burden prior to definitive oncologic surgery. These agents clearly provide a survival benefit, but also have the potential to adversely affect the surgical course of immediate and delayed breast reconstruction. The use of new biologic and hormonal agents may also have effects on surgery and reconstruction. Furthermore, chemotherapeutic agents as a whole may impair cellular functions necessary for normal recovery from surgery. In this paper we present a concise review for the reconstructive surgeon on adverse effects of chemotherapeutic, hormonal and biologic agents used for treatment of breast cancer, important perioperative issues, and also discuss their potential effect on breast reconstruction.

KW - Biologic

KW - Breast cancer

KW - Breast reconstruction

KW - Chemotherapy

KW - Hormonal

UR - http://www.scopus.com/inward/record.url?scp=84866348818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866348818&partnerID=8YFLogxK

U2 - 10.1016/j.bjps.2012.04.053

DO - 10.1016/j.bjps.2012.04.053

M3 - Review article

C2 - 22633392

AN - SCOPUS:84866348818

VL - 65

JO - Journal of Plastic, Reconstructive and Aesthetic Surgery

JF - Journal of Plastic, Reconstructive and Aesthetic Surgery

SN - 1748-6815

IS - 10

ER -